Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.4% | −6.3% | −1.7% | −14.3% | +19.3% | +28.0% | +118.4% | +13.7% | +156.9% | +797.3% |
| Peer average | −1.2% | −4.0% | +2.1% | −3.2% | +18.2% | +23.3% | +71.2% | +24.1% | +174.3% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$25 of every $1,000 in XBI is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 2.46% | $245.99 | 1.1M | $239.7M |
| 2 | BIIBBiogen | Healthcare | 1.85% | $185.02 | 716K | $180.3M |
| 3 | AMGNAmgen | Healthcare | 1.83% | $183.06 | 386K | $178.4M |
| 4 | REGNRegeneron Pharmaceuticals | Healthcare | 1.83% | $183.00 | 187K | $178.3M |
| 5 | ABBVAbbvie | Healthcare | 1.82% | $181.88 | 602K | $177.2M |
| 6 | UTHRUnited Therapeutics | Healthcare | 1.80% | $179.72 | 298K | $175.1M |
| 7 | GILDGilead Sciences | Healthcare | 1.79% | $178.56 | 1.0M | $174.0M |
| 8 | EXELExelixis | Healthcare | 1.79% | $178.52 | 2.6M | $174.0M |
| 9 | TGTXTG Therapeutics | Healthcare | 1.78% | $178.22 | 2.8M | $173.7M |
| 10 | SYRESpyre Therapeutics | Healthcare | 1.77% | $177.40 | 1.7M | $172.9M |
| 11 | ORKAOruka Therapeutics | Healthcare | 1.68% | $168.32 | 1.7M | $164.0M |
| 12 | NBIXNeurocrine Biosciences | Healthcare | 1.65% | $165.36 | 975K | $161.1M |
| 13 | VRTXVertex Pharmaceuticals | Healthcare | 1.60% | $160.17 | 290K | $156.1M |
| 14 | ALKSAlkermes | Healthcare | 1.59% | $159.06 | 3.3M | $155.0M |
| 15 | BBIOBridgebio Pharma | Healthcare | 1.58% | $157.80 | 2.0M | $153.8M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 2.46% |
| 2 | BIIB | Biogen | 1.85% |
| 3 | AMGN | Amgen | 1.83% |
| 4 | REGN | Regeneron Pharmaceuticals | 1.83% |
| 5 | ABBV | Abbvie | 1.82% |
| 6 | UTHR | United Therapeutics | 1.80% |
| 7 | GILD | Gilead Sciences | 1.79% |
| 8 | EXEL | Exelixis | 1.79% |
| 9 | TGTX | TG Therapeutics | 1.78% |
| 10 | SYRE | Spyre Therapeutics | 1.77% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 22, 2026 | Jun 24, 2026 | $0.14 |
| Dec 22, 2025 | Dec 24, 2025 | $0.41 |
| Sep 22, 2025 | Sep 24, 2025 | $0.0267 |
| Jun 23, 2025 | Jun 25, 2025 | $0.0073 |
| Mar 24, 2025 | Mar 26, 2025 | $0.0053 |
| Dec 23, 2024 | Dec 26, 2024 | $0.0027 |
| Sep 23, 2024 | Sep 25, 2024 | $0.0152 |
| Jun 24, 2024 | Jun 26, 2024 | $0.11 |
| Dec 18, 2023 | Dec 21, 2023 | $0.0139 |
| Jun 20, 2023 | Jun 23, 2023 | $0.0026 |
| Mar 22, 2021 | Mar 25, 2021 | $0.0400 |
| Dec 21, 2020 | Dec 24, 2020 | $0.18 |